Effect of Treatment With Fingolimod on the Immune Response Following Seasonal Flu Vaccination and Tetanus Booster Injection in Patients With Relapsing Multiple Sclerosis (MS)

• Status: Completed
• Trial end date: 2011-05-01

Summary

This study will evaluate the effect of treatment with fingolimod on the immune response following seasonal influenza vaccination and tetanus booster injection in patients with relapsing MS.

• Phase: Phase 3

Details

• Lead Sponsor: Novartis
• Treatments: Fingolimod Hydrochloride; Vaccines